Sparidans R | Utrecht University Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical An
スポンサーリンク
概要
- SPARIDANS Rolf W.の詳細を見る
- 同名の論文著者
- Utrecht University Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical Anの論文著者
関連著者
-
Sparidans R
Utrecht University Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical An
-
Beijnen J
Department Of Pharmacy & Pharmacology The Netherlands Cancer Institute/slotervaart Hospital
-
Beijnen Jos
University Of Utrecht Department Of Pharmaceutical Analysis
-
Schellens J
Utrecht University Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical An
-
Beijnen Jos
Slotervaart Hospital Department Of Pharmacy And Pharmacology
-
Schellens J.
Utrecht University Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical An
-
Schellens J.
Department Of Medical Oncology Antoni Van Leeuwenhoek Hospital/the Netherlands Cancer Institute
-
Beijnen Jos
Utrecht University Faculty Of Pharmacy Department Of Biomedical Analysis Division Of Drug Toxicology
-
Sparidans Rolf
Utrecht University Faculty Of Pharmacy Department Of Biomedical Analysis Division Of Drug Toxicology
-
SCHELLENS Jan
Utrecht University, Faculty of Science, Department of Pharmaceutical Sciences, Section of Biomedical
-
SPARIDANS Rolf
Utrecht University, Faculty of Pharmacy, Department of Pharmaceutical Analysis
-
BEIJNEN Jos
Utrecht University, Faculty of Pharmacy, Department of Pharmaceutical Analysis
-
BEIJNEN Jos
University of Utrecht, Department of Pharmaceutical Analysis
-
Schinkel Afred
The Netherlands Cancer Institute Departments Of Medical Oncology And Experimental Therapy
-
SPARIDANS Rolf
Universiteit Utrecht, Faculty of Science, Department of Pharmaceutical Sciences, Section of Biomedic
-
SCHELLENS Jan
Universiteit Utrecht, Faculty of Science, Department of Pharmaceutical Sciences, Section of Biomedic
-
Van Den
Utrecht University Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical An
-
Van Den
Utrecht University Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical An
-
LAGAS Jurjen
The Netherlands Cancer Institute, Departments of Medical Oncology and Experimental Therapy
-
Lagas Jurjen
The Netherlands Cancer Institute Departments Of Medical Oncology And Experimental Therapy
-
HENRAR Roland
EORTC-NDDO, Free University Hospital
-
JIMENO Jose
PharmaMar, Research & Development
-
FAIRCLOTH Glynn
PharmaMar, Research & Development
-
FLORIANO Pablo
PharmaMar, Research & Development
-
Jimeno Jose
Pharmamar S.a. Research And Development
-
Henrar Roland
Eortc-nddo Free University Hospital
-
Floriano Pablo
Pharmamar S.a. Research And Development
-
Faircloth Glynn
Pharmamar Usa Inc.
-
IUSUF Dilek
The Netherlands Cancer Institute, Division of Molecular Biology
-
SCHINKEL Alfred
The Netherlands Cancer Institute, Division of Molecular Biology
-
Iusuf Dilek
The Netherlands Cancer Institute Division Of Molecular Biology
-
Rinehart Kenneth
Roger Adams Laboratory University Of Illinois
-
Lingeman H
Free University Amsterdam Department Of Analytical Chemistry And Applied Spectroscopy
-
Bosch T.
Slotervaart Hospital Department Of Pharmacy And Pharmacology
-
Kettenes-van Den
Utrecht University Faculty Of Pharmacy Department Of Pharmaceutical Analysis
-
BEIJNEN Jos
Department of Pharmacy & Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute
-
VAN TELLINGEN
The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital
-
NUYEN Bastiaan
Slotervaart Hospital, Department of Pharmacy and Pharmacology
-
Underberg W
Utrecht Univ. Utrecht Nld
-
Rosing Hilde
Department Of Pharmacy & Pharmacology The Netherlands Cancer Institute/slotervaart Hospital
-
Rosing Hilde
Slotervaart Hospital Department Of Pharmacy And Pharmacology
-
Beijnen Jos
Department Of Clinical Chemistry The Netherlands Cancer Institute
-
Beijnen Jos
Department Of Pharmacy And Pharmacology The Netherlands Cancer Institute/slotervaart Hospital
-
Nuyen Bastiaan
Slotervaart Hospital Department Of Pharmacy And Pharmacology
-
BULT Auke
Department of Biomedical Analysis, Faculty of Pharmaceutical Sciences, Utrecht University
-
WATERVAL Joop
Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital
-
BLOKS Jeroen
Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital
-
SPARIDANS Rolf
Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital
-
RODRIGUEZ-CAMPOS Ignacio
Department Synthetic Processes, PharmaMar
-
BULT Auke
Free University Amsterdam, Department of Analytical Chemistry and Applied Spectroscopy
-
LINGEMAN Henk
Free University Amsterdam, Department of Analytical Chemistry and Applied Spectroscopy
-
UNDERBERG Willy
Utrecht University, Faculty of Pharmacy, Department of Biomedical Analysis
-
Bult Auke
Free University Amsterdam Department Of Analytical Chemistry And Applied Spectroscopy
-
Bloks Jeroen
Department Of Pharmacy And Pharmacology The Netherlands Cancer Institute/slotervaart Hospital
-
Waterval Joop
Department Of Pharmacy And Pharmacology The Netherlands Cancer Institute/slotervaart Hospital
-
Underberg Willy
Department Of Analytical Pharmacy Subfaculty Of Pharmacy State Univeristy Of Utrecht.
-
Rodriguez-campos Ignacio
Department Synthetic Processes Pharmamar
-
SCHINKEL Afred
The Netherlands Cancer Institute, Departments of Medical Oncology and Experimental Therapy
-
JORGER M.
The Netherlands Cancer Institute, Department of Medical Oncology
-
CROMMENTUYN Kristel
Slotervaart Hospital, Department of Pharmacy and Pharmacology
-
Jorger M.
The Netherlands Cancer Institute Department Of Medical Oncology
-
VAN VELSEN
University Medical Centre Utrecht, Department of Dermatology and Allergology
-
DE ROOS
Universiteit Utrecht, Faculty of Science, Department of Pharmaceutical Sciences, Section of Biomedic
-
BRUIJNZEEL-KOOMEN Carla
University Medical Centre Utrecht, Department of Dermatology and Allergology
-
VLAMING Maria
The Netherlands Cancer Institute, Departments of Medical Oncology and Experimental Therapy
-
Crommentuyn Kristel
Slotervaart Hospital Department Of Pharmacy And Pharmacology
-
De Roos
Universiteit Utrecht Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical
-
Van Velsen
University Medical Centre Utrecht Department Of Dermatology And Allergology
-
Vlaming Maria
The Netherlands Cancer Institute Departments Of Medical Oncology And Experimental Therapy
-
GOEY Andrew
Utrecht University, Faculty of Science, Department of Pharmaceutical Sciences, Section of Biomedical
-
MEIJERMAN Irma
Utrecht University, Faculty of Science, Department of Pharmaceutical Sciences, Section of Biomedical
-
Meijerman Irma
Utrecht University Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical An
-
Bruijnzeel-koomen Carla
University Medical Centre Utrecht Department Of Dermatology And Allergology
-
Goey Andrew
Utrecht University Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical An
著作論文
- Bioanalysis of aplidine, a new marine antitumoral depsipeptide, in plasma by high-performance liquid chromatography after derivatization with trans-4'-hydrazino-2-stilbazole
- Degradation kinetics of aplidine, a new marine antitumoural cyclic peptide, in aqueous solution
- Enzymatic digestion as a tool for the LC-MS/MS quantification of large peptides in biological matrices : Measurement of chymotryptic fragments from the HIV-1 fusion inhibitor enfuvirtide and its metabolite M-20 in human plasma
- Liquid chromatography-tandem mass spectrometric assays for salinomycin in mouse plasma, liver brain and small intestinal contents and in OptiMEM cell culture medium
- Liquid chromatography-tandem mass spectrometric assay for the analysis of uracil, 5,6-dihydrouracil and β-ureidopropionic acid in urine for the measurement of the activities of the pyrimidine catabolic enzymes
- Liquid chromatographic assay for the antiviral nucleotide analogue tenofovir in plasma using derivatization with chloroacetaldehyde
- Bioanalysis of thiocoraline, a new marine antitumoral depsipeptide, in plasma by high-performance liquid chromatography and fluorescence detection
- Liquid chromatography-tandem mass spectrometric assay for pravastatin and two isomeric metabolites in mouse plasma and tissue homogenates
- Validation of a quantitative assay for human neutrophil peptide-1, -2, and -3 in human plasma and serum by liquid chromatography coupled to tandem mass spectrometry
- Liquid chromatography-tandem mass spectrometric assay for clobetasol propionate in human serum from patients with atopic dermatitis
- Quantitative assay for six potential breast cancer biomarker peptides in human serum by liquid chromatography coupled to tandem mass spectrometry
- Liquid chromatography-tandem mass spectrometric assay for the light sensitive tyrosine kinase inhibitor axitinib in human plasma
- Liquid chromatography-tandem mass spectrometric assay for sorafenib and sorafenib-glucuronide in mouse plasma and liver homogenate and identification of the glucuronide metabolite
- Liquid chromatography-tandem mass spectrometric assay for diclofenac and three primary metabolites in mouse plasma
- Quantitative bioanalysis of peptides by liquid chromatography coupled to (tandem) mass spectrometry
- A sensitive LC-MS/MS method for the quantitative analysis of the Echinacea purpurea constituent undeca-2-ene-8,10-diynoic acid isobutylamide in human plasma